Efficacy and Safety of VMAT2 Inhibitors in the Treatment of Huntington Disease
In patients with HD, treatment with VMAT2is improved chorea (UHDRS-TMC and CGI-C), with no significant changes in adverse effects or depressive symptoms. These findings indicate that VMAT2is may be a promising and safe treatment option for the disease.
Authors
- Elder Machado Leite
- Golding Rodrigues
- João Eduardo Silva Lima
- Armando Leão Lages
- Adelson Barroso Junior
- José Arnaldo Cavalcanti Amorim
- José Fernando Barbosa Moura
Institutions
- Universidade de Pernambuco (BR)
- Universidade Federal de Alagoas (BR)
Publication Details
- Journal
- Neurology Clinical Practice
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1212/cpj.0000000000200578
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00